基于18F-FDG PET/CT影像组学列线图对儿童神经母细胞瘤骨髓浸润的诊断价值
本研究回顾性纳入144例神经母细胞瘤患儿,构建并验证基于18F-FDG PET/CT的影像组学列线图,用于诊断骨髓浸润。列线图整合影像组学特征、独立临床危险因素和SUVmean,在训练集和验证集的AUC分别为0.963和0.931,决策曲线分析显示临床有用。
要点
- 列线图诊断骨髓浸润训练集AUC 0.963、验证集AUC 0.931。
- 列线图整合影像组学特征、临床危险因素和SUVmean。
- 骨髓穿刺或活检为骨髓浸润的诊断金标准。
核心结论
- 基于18F-FDG PET/CT的影像组学列线图可提高儿童神经母细胞瘤骨髓浸润的诊断性能,且不增加医疗成本和辐射暴露。
研究设计与样本
- 回顾性研究,纳入144例神经母细胞瘤患者(训练集100例,验证集44例),以骨髓穿刺或活检结果为金标准。
- 使用3D Slicer提取影像组学特征和常规PET参数,通过LASSO回归筛选特征并构建影像组学标签。
- 采用单变量和多变量逻辑回归构建临床模型、常规PET模型、PET-临床联合模型和影像组学联合模型,并以列线图呈现联合模型。
- 通过ROC曲线和决策曲线分析评估各模型诊断性能。
关键影像表现/征象
- 视觉评估显示80例患者存在骨髓浸润。
- 提取了4个常规PET参数:SUVmax、SUVmean、代谢肿瘤体积和总病灶糖酵解。
- 筛选出15个影像组学特征构建影像组学标签。
诊断标准与关键数值
- 列线图整合影像组学标签、独立临床危险因素(11q异常、神经元特异性烯醇化酶、香草扁桃酸)和SUVmean。
- 列线图在训练集和验证集的AUC分别为0.963和0.931。
- 决策曲线分析表明列线图具有临床实用性。
临床应用与阅片要点
- 在日常阅片和报告中,可结合影像组学列线图评估儿童神经母细胞瘤骨髓浸润风险。
- 列线图整合了影像组学特征、临床危险因素和常规PET参数,有助于提高诊断准确性。
局限性
- 回顾性研究设计。
- 样本量有限(共144例)。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and validate an 18F-FDG PET/CT-based radiomics nomogram and evaluate the value of the 18F-FDG PET/CT-based radiomics nomogram for the diagnosis of bone marrow involvement (BMI) in pediatric neuroblastoma.
MATERIALS AND METHODS: A total of 144 patients with neuroblastoma (100 in the training cohort and 44 in the validation cohort) were retrospectively included. The PET/CT images of patients were visually assessed. The results of bone marrow aspirates or biopsies were used as the gold standard for BMI. Radiomics features and conventional PET parameters were extracted using the 3D slicer. Features were selected by the least absolute shrinkage and selection operator regression, and radiomics signature was constructed. Univariate and multivariate logistic regression analyses were applied to identify the independent clinical risk factors and construct the clinical model. Other different models, including the conventional PET model, combined PET-clinical model and combined radiomics model, were built using logistic regression. The combined radiomics model was based on clinical factors, conventional PET parameters and radiomics signature, which was presented as a radiomics nomogram. The diagnostic performance of the different models was evaluated by receiver operating characteristic (ROC) curves and decision curve analysis (DCA).
RESULTS: By visual assessment, BMI was observed in 80 patients. Four conventional PET parameters (SUVmax, SUVmean, metabolic tumor volume, and total lesion glycolysis) were extracted. And 15 radiomics features were selected to build the radiomics signature. The 11q aberration, neuron-specific enolase and vanillylmandelic acid were identified as the independent clinical risk factors to establish the clinical model. The radiomics nomogram incorporating the radiomics signature, the independent clinical risk factors and SUVmean demonstrated the best diagnostic value for identifying BMI, with an area under the curve (AUC) of 0.963 and 0.931 in the training and validation cohorts, respectively. And the DCA demonstrated that the radiomics nomogram was clinically useful.
CONCLUSION: The 18F-FDG PET/CT-based radiomics nomogram which incorporates radiomics signature, independent clinical risk factors and conventional PET parameters could improve the diagnostic performance for BMI of pediatric neuroblastoma without additional medical costs and radiation exposure.
引用
- Feng, Yang, Lu, et al. Diagnostic Value of 18F-FDG PET/CT-Based Radiomics Nomogram in Bone Marrow Involvement of Pediatric Neuroblastoma. Acad Radiol. 2022. PMID: 36117128. doi:10.1016/j.acra.2022.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。